We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ABCAP:AQUISEUABC arbitrage SA Analysis

Data as of 2026-05-25 - not real-time

₹363.65

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Aditya Birla Capital is trading at ₹363.65, comfortably above its 20‑day (₹352.78), 50‑day (₹335.41) and 200‑day (₹326.17) moving averages, indicating a sustained bullish bias. The RSI of 59.8 suggests momentum is still healthy, while the MACD histogram has turned negative, hinting at a short‑term pull‑back. Revenue grew 7.7% YoY to INR 323 bn and profit margins remain solid at ~11.6%, supported by a 32% expansion in the lending book and the onboarding of 1.1 crore customers on the direct‑to‑consumer platform. Analysts have upgraded the stock to a strong‑buy with a median price target of ₹412.5, implying roughly 13% upside, and Macquarie maintains an Outperform rating with a target of ₹415. Valuation appears mixed: the trailing PE of 25.5x exceeds the industry average of 16.8x, yet the forward PE of 14.8x aligns with growth expectations. The balance sheet is leveraged, reflected by a debt‑to‑equity ratio above 490, and operating cash flow is negative, but the company’s ROE of 11% and strong earnings growth mitigate some concerns. Overall, the stock combines robust earnings momentum and attractive analyst targets with elevated leverage and a slight technical warning, suggesting a cautious but optimistic outlook.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price above key moving averages
  • Negative MACD histogram
  • Decreasing volume trend

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Analyst consensus strong‑buy with median target ₹412.5
  • Revenue and profit growth accelerating
  • Forward PE of 14.8x indicating value relative to growth

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Expanding loan portfolio and digital customer base
  • Strong brand and diversified financial services franchise
  • Resilient earnings despite high leverage

Key Metrics & Analysis

Financial Health

Revenue Growth7.70%
Profit Margin11.65%
P/E Ratio25.5
ROE11.18%
ROA1.26%
Debt/Equity491.75
P/B Ratio2.8
Op. Cash Flow₹-365441187840
Industry P/E16.8

Technical Analysis

TrendBullish
RSI59.8
Support₹337.45
Resistance₹375.95
MA 20₹352.79
MA 50₹335.41
MA 200₹326.17
MACDBearish
VolumeDecreasing
Fear & Greed Index91.8

Valuation

Target Price₹411.42
Upside/Downside13.14%
GradeFair
TypeGrowth

Risk Assessment

Beta0.61
Volatility28.92%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.